IL160852A0 - Pharmaceutical compositions for the treatment of urinary disorders - Google Patents

Pharmaceutical compositions for the treatment of urinary disorders

Info

Publication number: IL160852A0
Authority: IL; Israel
Prior art keywords: treatment; pharmaceutical compositions; urinary disorders; urinary; disorders
Prior art date: 2001-09-27

Application number

IL16085202A

Original Assignee

Pharmacia Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-09-27

Filing date

2002-09-26

Publication date

2004-08-31

2001-09-27 Priority claimed from US09/965,556 external-priority patent/US20030060513A1/en

2002-09-26 Application filed by Pharmacia Ab filed Critical Pharmacia Ab

2004-08-31 Publication of IL160852A0 publication Critical patent/IL160852A0/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Urology & Nephrology (AREA)
Emergency Medicine (AREA)
Psychiatry (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

IL16085202A 2001-09-27 2002-09-26 Pharmaceutical compositions for the treatment of urinary disorders IL160852A0 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US09/965,556 US20030060513A1 (en)	2001-09-27	2001-09-27	Pharmaceutical composition
SE0103858A SE0103858D0 (en)	2001-09-27	2001-11-20	Pharmaceutical composition
PCT/SE2002/001748 WO2003026564A2 (en)	2001-09-27	2002-09-26	Pharmaceutical compositions for the treatment of urinary disorders

Publications (1)

Publication Number	Publication Date
IL160852A0 true IL160852A0 (en)	2004-08-31

Family

ID=26655594

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL16085202A IL160852A0 (en)	2001-09-27	2002-09-26	Pharmaceutical compositions for the treatment of urinary disorders

Country Status (9)

Country	Link
EP (1)	EP1438035A2 (en)
JP (1)	JP2005503424A (en)
KR (1)	KR20040039436A (en)
CN (1)	CN1558756A (en)
BR (1)	BR0212824A (en)
CA (1)	CA2461731A1 (en)
IL (1)	IL160852A0 (en)
MX (1)	MXPA04002496A (en)
WO (1)	WO2003026564A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0957073A1 (en)	1998-05-12	1999-11-17	Schwarz Pharma Ag	Novel derivatives of 3,3-diphenylpropylamines
FR2843303B1 (en) *	2002-08-07	2006-01-21	R & D Pharma	NOVEL PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF URINARY INCONTINENCE
DE10315917A1 (en) *	2003-04-08	2004-11-18	Schwarz Pharma Ag	Highly pure bases of 3,3-diphenylpropylamine monoesters
CN100382794C (en) *	2004-08-30	2008-04-23	鲁南制药集团股份有限公司	Dispersed tablet of tartaric acid tolterodine tartrate
WO2009151613A1 (en) *	2008-06-13	2009-12-17	Concert Pharmaceuticals, Inc.	Oxybutynin derivatives
JP5553767B2 (en) *	2008-11-07	2014-07-16	大日本住友製薬株式会社	New and useful treatment for lower urinary tract symptoms
GB2571696B (en)	2017-10-09	2020-05-27	Compass Pathways Ltd	Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
CA3138008A1 (en)	2019-04-17	2020-10-22	Compass Pathfinder Limited	Methods of treating neurocognitive disorders, chronic pain and reducing inflammation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9417135D0 (en) *	1994-08-23	1994-10-12	Medinnova S F	Method
IT1282705B1 (en) *	1996-02-28	1998-03-31	Recordati Chem Pharm	USE OF 5-HT \| A SEROTONINERGIC RECEPTOR ANTAGONISTS FOR THE TREATMENT OF URINARY INCONTINENCE
PE92198A1 (en) *	1996-08-01	1999-01-09	Banyu Pharma Co Ltd	DERIVATIVES OF FLUORINE-CONTAINED 1,4-PIPERIDINE
WO1999021563A1 (en) *	1997-10-28	1999-05-06	Merck & Co., Inc.	Prevention of precipitated acute urinary retention
AU7703700A (en) *	1999-09-22	2001-04-24	Merck & Co., Inc.	Treatment of lower urinary tract symptoms and pharmaceutical compositions for use therein
IT1314192B1 (en) *	1999-10-18	2002-12-06	Recordati Chem Pharm	BENZOPYRANIC DERIVATIVES

2002
- 2002-09-26 KR KR10-2004-7004529A patent/KR20040039436A/en not_active Application Discontinuation
- 2002-09-26 IL IL16085202A patent/IL160852A0/en unknown
- 2002-09-26 EP EP02775633A patent/EP1438035A2/en not_active Withdrawn
- 2002-09-26 CA CA002461731A patent/CA2461731A1/en not_active Abandoned
- 2002-09-26 BR BR0212824-1A patent/BR0212824A/en not_active IP Right Cessation
- 2002-09-26 MX MXPA04002496A patent/MXPA04002496A/en unknown
- 2002-09-26 CN CNA028188764A patent/CN1558756A/en active Pending
- 2002-09-26 WO PCT/SE2002/001748 patent/WO2003026564A2/en not_active Application Discontinuation
- 2002-09-26 JP JP2003530203A patent/JP2005503424A/en not_active Withdrawn

Also Published As

Publication number	Publication date
JP2005503424A (en)	2005-02-03
KR20040039436A (en)	2004-05-10
CA2461731A1 (en)	2003-04-03
MXPA04002496A (en)	2004-05-31
WO2003026564A3 (en)	2003-12-11
CN1558756A (en)	2004-12-29
WO2003026564A2 (en)	2003-04-03
WO2003026564A9 (en)	2004-06-17
BR0212824A (en)	2004-10-13
EP1438035A2 (en)	2004-07-21

Similar Documents

Publication	Publication Date	Title
IL157734A0 (en)	2004-03-28	Pharmaceutical compositions for the treatment of urogenital disorders
HUP0401514A3 (en)	2012-08-28	Pharmaceutical compositions for the treatment of asthma
ZA200401004B (en)	2006-03-29	Combination for the treatment of inflammatory disorders
GB0010669D0 (en)	2000-06-28	Compositions for treatment of disorders of the oesophagus
HUP0600781A2 (en)	2007-01-29	Compounds for the treatment of metabolic disorders and pharmaceutical compositions containing them
IL159344A0 (en)	2004-06-01	Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
IL160884A0 (en)	2004-08-31	Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
HUP0202719A3 (en)	2006-01-30	Pharmaceutical compositions for the treatment of female sexual dysfunctions
IL162485A0 (en)	2005-11-20	Compounds for the treatment of inflammatory disorders
AU2003274342A8 (en)	2004-05-04	Compositions for the treatment of autoimmune disorders
IL161070A0 (en)	2004-08-31	Compositions for the treatment of infectious diseases
AU2002356525A1 (en)	2003-04-07	Substituted amines for the treatment of neurological disorders
IL161267A0 (en)	2004-09-27	Combinations for the treatment of immunoinflammatory disorders
SI1432701T1 (en)	2006-04-30	Heterocyclic compounds for use in the treatment of disorders of the urinary tract
AU2002240359A1 (en)	2002-08-28	Pharmaceutical composition for the treatment of alopecia
HUP0401427A3 (en)	2007-10-29	Oral compositions for the treatment of scalp disorders
EP1461030A4 (en)	2005-06-01	Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma
IL160852A0 (en)	2004-08-31	Pharmaceutical compositions for the treatment of urinary disorders
AU2002258798A1 (en)	2002-10-28	Methods for the treatment of hepatic disorders
AU2003283153A8 (en)	2004-02-25	Pharmaceutical compositions for the treatment of urinary incontinence
HUP0200253A3 (en)	2003-04-28	Pharmaceutical compositions for combination therapy
AU2003240174A8 (en)	2003-12-22	Compositions for the treatment of edematous-firbrosclerotic panniculopathy
EP1402893A4 (en)	2006-02-08	Pharmaceutical compositions for treatment of secondary hyperparathyroidism and therapeutic agents for cardiovascular complications resulting from the treatment for secondary hyperparathyroidism.
AU2002338849A1 (en)	2003-04-22	Pharmaceutical composition for the treatment of disorders of non-human mammals
GB0125371D0 (en)	2001-12-12	Treatment of movement disorders